ArticleACS omega2026

Generative AI-Based Drug Design: Target-Aware Molecular Generation for EGFR Type I Inhibitors with Multiplatform Docking Validation.

Taqdees Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.